Search Results

Press Releases

Group FH ORTHO announced the Launch of JARVIS the New Round Baseplate for Reverse Prosthesis in the USA!

January 20, 2025

·

2 min read

Press Releases

Hemostemix’s Social Media Awareness of “Your Fountain of Youth"(TM) Regenerative Medicine Treatments Is Gaining Traction

Hemostemix is revolutionizing how individuals think about their own regenerative medicine treatments. With social media, the company is educating individuals about treatments and advancements.

January 2, 2025

·

6 min read

Biotech Beach

THINK Surgical to Collaborate with b-ONE Ortho Corporation for Robotic TKA

THINK Surgical, Inc. announced that it will enter into a new Collaboration Agreement with b-ONE Ortho Corporation.

February 14, 2024

·

3 min read

Business

Ortho Regenerative Technologies Announces Corporate Name Change to ChitogenX

Ortho Regenerative Technologies Inc. announced that it has changed its corporate name to ChitogenX Inc. to better reflect the Company’s expanded clinical and commercial opportunities, mission, values, and core competencies.

September 7, 2022

·

3 min read

Business

Harvard Apparatus Regenerative Technology Reports First Quarter 2024 Financial Results and Recent Business Highlights

Harvard Apparatus Regenerative Technology, Inc. (OTCQB: HRGN) (“Harvard Apparatus Regenerative Technology” or the “Company”), a clinical-stage biotechnology company developing the technology to regenerate organs inside the body to treat severe diseases, today reported first quarter 2024 financial results.

May 13, 2024

·

6 min read

Ortho Development Receives FDA Clearance on Trivicta Hip System

Ortho Development Corporation, a designer and manufacturer of orthopedic implants and instruments for hip and knee joint replacement surgery, today announced U.S. Food and Drug Administration (FDA) 510(k) clearance of the Trivicta™ Hip System.

March 14, 2024

·

1 min read

ORTHO REGENERATIVE TECHNOLOGIES RECEIVES $500,000 AXELYS GRANT TO ADVANCE ORTHO-M DEVELOPMENT FOR MENISCUS REPAIR

Ortho Regenerative Technologies Inc. announced today that it has received, through its partnership with Polytechnique Montreal, a $500,000 non-dilutive grant from Axelys, to advance the development of its second technology platform indication, ORTHO-M, for meniscus repair.

May 26, 2022

·

3 min read

ORTHO REGENERATIVE TECHNOLOGIES RECEIVES KEY U.S. COMPOSITION AND METHOD PATENT FOR ORTHO-R SOFT TISSUE REPAIR PLATFORM

Ortho Regenerative Technologies Inc. announced today that the United States Patent and Trademark Office (the “USPTO”) has issued a patent related to the Company’s ORTHO-R soft tissue repair platform.

May 4, 2022

·

3 min read

Business

Harvard Apparatus Regenerative Technology Reports Fourth Quarter and Full Year 2023 Financial Results and Recent Business Highlights

Harvard Apparatus Regenerative Technology, Inc. (OTCQB: HRGN) (“Harvard Apparatus Regenerative Technology” or the “Company”), a clinical-stage biotechnology company developing the technology to regenerate organs inside the body to treat severe diseases, today reported fourth quarter and full year 2023 financial results.

April 2, 2024

·

9 min read

Business

ORTHO REGENERATIVE TECHNOLOGIES ANNOUNCES EXECUTIVE LEADERSHIP CHANGES

Ortho Regenerative Technologies Inc. today announced the appointment of Philippe Deschamps as its new Chief Executive Officer following the retirement of Mr. LeDuc, the Company’s CEO for the last three years.

March 15, 2022

·

5 min read